CareDx Inc
NASDAQ:CDNA

Watchlist Manager
CareDx Inc Logo
CareDx Inc
NASDAQ:CDNA
Watchlist
Price: 18.83 USD -0.05%
Market Cap: 968.4m USD

Relative Value

The Relative Value of one CDNA stock under the Base Case scenario is hidden USD. Compared to the current market price of 18.83 USD, CareDx Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CDNA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
57
vs Industry
70
Median 3Y
2.2
Median 5Y
2.9
Industry
7.9
Forward
2.5
vs History
9
vs Industry
7
Median 3Y
-3.3
Median 5Y
-8
Industry
23.7
Forward
27.9
vs History
34
vs Industry
6
Median 3Y
18.1
Median 5Y
-24.9
Industry
22
vs History
25
vs Industry
6
Median 3Y
-12.6
Median 5Y
-19.9
Industry
24.3
vs History
39
vs Industry
32
Median 3Y
2.4
Median 5Y
2.8
Industry
3.3
vs History
52
vs Industry
64
Median 3Y
1.6
Median 5Y
2.4
Industry
8.2
Forward
2
vs History
52
vs Industry
63
Median 3Y
2.4
Median 5Y
3.6
Industry
10.2
vs History
vs Industry
34
Median 3Y
-9.4
Median 5Y
-23.1
Industry
6.1
Forward
21.4
vs History
vs Industry
33
Median 3Y
-7.6
Median 5Y
-16.5
Industry
6.5
Forward
46.6
vs History
34
vs Industry
8
Median 3Y
13.6
Median 5Y
-12.6
Industry
7.9
vs History
25
vs Industry
6
Median 3Y
-6.4
Median 5Y
-10.8
Industry
6.3
vs History
47
vs Industry
35
Median 3Y
2.3
Median 5Y
3.4
Industry
5.7

Multiples Across Competitors

CDNA Competitors Multiples
CareDx Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
CareDx Inc
NASDAQ:CDNA
968.5m USD 2.7 15.9 -35 -21.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 790 068.7 -160 599.2 -195 018.6 -192 793.3
US
Abbvie Inc
NYSE:ABBV
400.3B USD 6.7 171.1 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
175B USD 4.9 25.2 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
151B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.2B USD 9.8 31.3 22.8 23.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 084.9 -532 -579.3 -563.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.1B USD 5.7 17.8 16.9 19.2
AU
CSL Ltd
ASX:CSL
83.3B AUD 3.6 18.5 12.5 15.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.3B USD 16.4 1 207.1 161.9 196.4
NL
argenx SE
XBRU:ARGX
43.9B EUR 14.4 33.7 57.9 59.5
P/S Multiple
Revenue Growth P/S to Growth
US
CareDx Inc
NASDAQ:CDNA
Average P/S: 3 072 020.3
2.7
12%
0.2
FR
Pharnext SCA
OTC:PNEXF
33 790 068.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.8
10%
1
US
E
Epizyme Inc
F:EPE
2 084.9
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
6%
1
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.4
46%
0.4
NL
argenx SE
XBRU:ARGX
14.4
49%
0.3
P/E Multiple
Earnings Growth PEG
US
CareDx Inc
NASDAQ:CDNA
Average P/E: 171
15.9
7%
2.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 599.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
171.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.3
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
10%
1.8
AU
CSL Ltd
ASX:CSL
18.5
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 207.1
N/A N/A
NL
argenx SE
XBRU:ARGX
33.7
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
CareDx Inc
NASDAQ:CDNA
Average EV/EBITDA: 39.9
Negative Multiple: -35
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 018.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.8
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
11%
1.5
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
161.9
N/A N/A
NL
argenx SE
XBRU:ARGX
57.9
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
CareDx Inc
NASDAQ:CDNA
Average EV/EBIT: 46.1
Negative Multiple: -21.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 793.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.8
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
13%
1.5
AU
CSL Ltd
ASX:CSL
15.6
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
196.4
N/A N/A
NL
argenx SE
XBRU:ARGX
59.5
N/A N/A